Scholarly Index
Diane V. Havlir
University of California, San Francisco; 45,994 total citations; 530 total publications; best world rank #41
University of California, San Francisco
45,994Total citations
530Total publications
90H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| HIV/AIDS Research and Interventions | Lifetime | 45 | US 29 | 99.80 |
| HIV/AIDS drug development and treatment | Lifetime | 41 | US 24 | 99.72 |
| HIV Research and Treatment | Lifetime | 97 | US 68 | 99.65 |
| Pneumocystis jirovecii pneumonia detection and treatment | Lifetime | 54 | US 20 | 99.50 |
| Tuberculosis Research and Epidemiology | Lifetime | 173 | US 64 | 99.24 |
| Mycobacterium research and diagnosis | Lifetime | 346 | US 128 | 98.18 |
| HIV-related health complications and treatments | Lifetime | 153 | US 92 | 98.52 |
| HIV, Drug Use, Sexual Risk | Lifetime | 290 | US 179 | 98.29 |
| Diagnosis and treatment of tuberculosis | Lifetime | 301 | US 82 | 96.13 |
| HIV/AIDS Research and Interventions | 2021-2025 | 85 | US 38 | 98.61 |
| HIV, Drug Use, Sexual Risk | 2021-2025 | 249 | US 129 | 95.17 |
| HIV Research and Treatment | 2021-2025 | 357 | US 172 | 93.23 |
| HIV/AIDS drug development and treatment | 2021-2025 | 843 | US 283 | 83.26 |
| HIV-related health complications and treatments | 2021-2025 | 950 | US 353 | 75.94 |
| HIV/AIDS Impact and Responses | 2021-2025 | 927 | US 218 | 44.71 |